textabstractBackground The aim of this study was to validate the Mantle Cell Lymphoma International Prognostic Index in a population-based cohort and to study the relevance of its revisions. Design and Methods We analyzed data from 178 unselected patients with stage III or IV mantle cell lymphoma, registered between 1994 and 2006 in the Eindhoven Cancer Registry. Follow-up was completed up to January 1st, 2008. Multiple imputations for missing
International audienceDifferent histopathologic classifications have been used in the study of malig...
: Currently, treatment allocation of patients with Mantle Cell Lymphoma (MCL) is mainly based on age...
Aim: To compare the outcomes of Croatian patients with mantle cell lymphoma (MCL) who started treatm...
Purpose Mantle-cell lymphoma (MCL) is a distinct B-cell lymphoma associated with poor outcome. In 20...
textabstractBackground: The aim of this study was to validate the Follicular Lymphoma International ...
There is no generally established prognostic index for patients with mantle cell lymphoma (MCL), bec...
Purpose Mantle-cell lymphoma (MCL) is a rather aggressive B-cell malignancy whose considerable varia...
PurposeMantle-cell lymphoma (MCL) is a rather aggressive B-cell malignancy whose considerable variab...
Introduction: Mantle cell lymphoma is a B-cell non-Hodgkin’s lymphoma characterized by a t(11;14), r...
INTRODUCTION: Mantle cell lymphoma is a B-cell non-Hodgkin's lymphoma characterized by a t(11;14), r...
Mantle cell lymphoma (MCL) is still considered incurable and the course of the disease is highly var...
PURPOSE: Mantle cell lymphoma (MCL) is a rare non-Hodgkin's lymphoma entity with a poor prognosis. T...
Patients and methods: Data of 353 unselected patients, 1993-2002, in the Eindhoven Cancer Registry, ...
Abstract In recent years, more intensive chemotherapy regimens for mantle cell lymphoma (MCL) have b...
outcome in primary gastric DLBC lymphoma We read with interest the original article published in the...
International audienceDifferent histopathologic classifications have been used in the study of malig...
: Currently, treatment allocation of patients with Mantle Cell Lymphoma (MCL) is mainly based on age...
Aim: To compare the outcomes of Croatian patients with mantle cell lymphoma (MCL) who started treatm...
Purpose Mantle-cell lymphoma (MCL) is a distinct B-cell lymphoma associated with poor outcome. In 20...
textabstractBackground: The aim of this study was to validate the Follicular Lymphoma International ...
There is no generally established prognostic index for patients with mantle cell lymphoma (MCL), bec...
Purpose Mantle-cell lymphoma (MCL) is a rather aggressive B-cell malignancy whose considerable varia...
PurposeMantle-cell lymphoma (MCL) is a rather aggressive B-cell malignancy whose considerable variab...
Introduction: Mantle cell lymphoma is a B-cell non-Hodgkin’s lymphoma characterized by a t(11;14), r...
INTRODUCTION: Mantle cell lymphoma is a B-cell non-Hodgkin's lymphoma characterized by a t(11;14), r...
Mantle cell lymphoma (MCL) is still considered incurable and the course of the disease is highly var...
PURPOSE: Mantle cell lymphoma (MCL) is a rare non-Hodgkin's lymphoma entity with a poor prognosis. T...
Patients and methods: Data of 353 unselected patients, 1993-2002, in the Eindhoven Cancer Registry, ...
Abstract In recent years, more intensive chemotherapy regimens for mantle cell lymphoma (MCL) have b...
outcome in primary gastric DLBC lymphoma We read with interest the original article published in the...
International audienceDifferent histopathologic classifications have been used in the study of malig...
: Currently, treatment allocation of patients with Mantle Cell Lymphoma (MCL) is mainly based on age...
Aim: To compare the outcomes of Croatian patients with mantle cell lymphoma (MCL) who started treatm...